Categories: PR Newswire

The Myeloma Crowd Launches Psoriasis / Multiple Myeloma Study Using Its HealthTree® Platform

SALT LAKE CITY, Oct. 2, 2019 /PRNewswire/ — The Myeloma Crowd, a division of the CrowdCare Foundation, today announced the launch of a new study to identify correlations between psoriasis and multiple myeloma. Psoriasis is an auto-immune disease of the skin and multiple myeloma is a rare blood cancer in which the cancer has escaped the immune system.

Participants will join the study via the HealthTree® platform, a new online tool that helps multiple myeloma patients find their best myeloma treatments and accelerate research toward a cure. There are currently more than 4,500 myeloma patients registered to HealthTree.

“This study demonstrates the importance of HealthTree as a tool for patients to connect with opportunities that could help them directly and accelerate a cure,” said Myeloma Crowd founder and myeloma patient Jenny Ahlstrom. “HealthTree has been designed as a model for curing disease by leveraging the crowd, starting with myeloma with the intent of expanding to other cancers and beyond.”

Research shows that multiple myeloma growth and bone damage can occur through activity of the interleukin-17 pathway. IL-17 is also a known treatment target in psoriasis, with several anti-IL-17 monoclonal antibodies currently FDA-approved as psoriasis therapy.  Other joint cytokines and targets may be applicable.

Dana Farber Cancer Institute researchers performed initial work assessing the utility of anti-IL-17 psoriasis mediations to treat multiple myeloma in mouse models. Further research is needed to identify possible connections between the two diseases.

The Myeloma Crowd invites all multiple myeloma patients with psoriasis to join this important study by registering in HealthTree and adding their psoriasis diagnosis to their full health profile.

HealthTree was developed by Myeloma Crowd founders Jenny Ahlstrom, who is also a former Systems Engineer for IBM, and her husband Paul Ahlstrom, an investor and entrepreneur. HealthTree is free for myeloma patients.

To join the psoriasis/myeloma study, create a patient profile on www.healthtree.org. Please note if you have psoriasis in the Full Health Profile and choose to join study by clicking the Accelerate Myeloma Research tile and selecting Yes on the Psoriasis survey question.

About Myeloma Crowd/CrowdCare Foundation

The Myeloma Crowd is a division of the CrowdCare Foundation, a patient-driven 501(c)3 non-profit organization. The Myeloma Crowd provides patient education, advocacy and research funding for multiple myeloma. www.myelomacrowd.org.

SOURCE Myeloma Crowd: CrowdCare Foundation

Related Links

https://www.myelomacrowd.org/

IR Press

Share
Published by
IR Press

Recent Posts

OCC Announces Enforcement Actions for November 2024

WASHINGTON—The Office of the Comptroller of the Currency (OCC) today released enforcement actions taken against…

1 day ago

Remarks by Secretary of the Treasury Janet L. Yellen on the 30th Anniversary of the Community Development Financial Institution Fund

As Prepared for Delivery Good afternoon. It’s an honor to welcome President Clinton to Treasury today…

2 days ago

Treasury Sanctions Gazprombank and Takes Additional Steps to Curtail Russia’s Use of the International Financial System

Treasury imposes sanctions on dozens of Russian banks, securities registrars, and finance officials; OFAC issues…

2 days ago

Acting Comptroller Testifies on State of the Federal Banking System

WASHINGTON—Acting Comptroller Michael J. Hsu today testified on the state of the federal banking system…

2 days ago

Remarks by Assistant Secretary for International Finance Brent Neiman on the U.S. Cross-Border Payments Agenda

As Prepared for Delivery Thank you very much for the opportunity to be here today, and…

4 days ago